Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | bambuterol | 54766 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | bambuterol | 54766 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | bambuterol | 54766 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bambuterol | 54766 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | bambuterol | 54766 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | bambuterol | 54766 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | bambuterol | 54766 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | naloxone | 5284596 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | naloxone | 5284596 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | naloxone | 5284596 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | naloxone | 5284596 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | naloxone | 5284596 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | naloxone | 5284596 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | naloxone | 5284596 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | naloxone | 5284596 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | apomorphine | 6005 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | apomorphine | 6005 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | apomorphine | 6005 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | apomorphine | 6005 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | practolol | 4883 | drug-path |